—
Understanding Immunophenotyping by Flow Cytometry CD138 Test
In the realm of medical diagnostics, precision is key. Among the various sophisticated tests available, the Immunophenotyping by Flow Cytometry CD138 Test stands out, especially in the context of diagnosing and monitoring plasma cell disorders. This test is pivotal in the identification of specific cell markers that are crucial in the immune response system. Conducted in specialized laboratories such as DNA Labs UAE, the CD138 Test plays a significant role in the assessment of various hematological malignancies.
Symptoms Leading to the Recommendation of CD138 Test
Patients might wonder what symptoms or conditions lead healthcare providers to recommend the CD138 Test. Typically, the test is advised when symptoms indicative of plasma cell disorders, such as multiple myeloma or other related conditions, are present. These symptoms include, but are not limited to:
- Unexplained bone pain, particularly in the spine or chest.
- Frequent infections due to compromised immunity.
- Anemia leading to fatigue and weakness.
- High levels of calcium in the blood, resulting in excessive thirst and urination.
- Kidney dysfunction or failure.
- Weight loss without a clear reason.
- Increased protein levels in the blood or urine, specifically monoclonal immunoglobulin.
It’s important to note that these symptoms can be indicative of various conditions and do not solely confirm the presence of a plasma cell disorder. The CD138 Test, however, can provide clarity by identifying the presence and extent of abnormal plasma cells.
The Role of CD138 Test in Diagnosis and Monitoring
The CD138 Test is not only crucial for the initial diagnosis but also plays a vital role in monitoring the progression of plasma cell disorders. By quantifying the number of CD138 positive cells, healthcare providers can assess the disease’s severity and response to treatment. This information is invaluable in tailoring treatment plans to the individual patient’s needs, potentially improving outcomes.
Test Cost and Availability at DNA Labs UAE
Understanding the financial aspect of healthcare is important for patients. At DNA Labs UAE, the Immunophenotyping by Flow Cytometry CD138 Test is offered at a cost of 480 AED. This investment in health allows for a comprehensive analysis that aids in the accurate diagnosis and effective management of plasma cell disorders.
For those interested in learning more about the CD138 Test or scheduling an appointment, further information can be found at DNA Labs UAE.
Conclusion
The Immunophenotyping by Flow Cytometry CD138 Test is a powerful tool in the diagnosis and management of plasma cell disorders. With symptoms ranging from bone pain to kidney dysfunction, it is crucial for patients experiencing these signs to consult with their healthcare provider about the possibility of undergoing this test. DNA Labs UAE stands ready to provide this essential diagnostic service, contributing to the effective treatment and better health outcomes for patients.
—
